Skip to content
  • Science & Innovation
  • About us
  • News
  • Science & Innovation
  • About us
  • News

Author: Valentin GEORGE

#AACR2024 Brenus Pharma unveils promising and robust pre-clinical efficacy extrapolating human conditions with STC-1010

France Biotech unveils the winners of the 2024 edition of the “HealthTech Trophies”: Spotlight on 9 innovative healthcare companies!

Brenus Pharma, winner of the call for proposals “Innovations in biotherapies and bioproduction for France 2030”, receives €5 Million for its anticancer immunotherapy

Brenus Pharma joins the Paris Saclay Cancer Cluster (PSCC) to collaborate at the heart of innovation in oncology

Brenus Pharma unveils promising pre-clinical results extrapolating human conditions in major international congresses

Brenus Pharma announces its international scientific committee

PHARMA MINDS – Taking the Leap: Paul Bravetti on Biotech, Risk & Innovation

PHARMACEUTIQUES – Brenus Pharma : The missing link in next-generation immunotherapies

#AACR2023 Brenus Pharma unveils groundbreaking preclinical results For STC-10101, a promising new drug candidate targeting colorectal cancer & solid tumors

French Blood Establishment (EFS) & Brenus Pharma partner for the GMP production of STC-1010, an innovative therapy against colorectal cancer

← Previous
Next →

Copyright 2025 Brenus Pharma – Tous droits réservés

4 rue Eric de Cromieres – 63000 CLERMONT-FERRAND
60 Quai Perrache – 69002 LYON, FRANCE

  • contact@brenus-pharma.com
  • Privacy Policy